Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine vs oxycodone vs fentanyl during propofol TCI sedation for colonoscopy
ChiCTR2300077446Phase 4Not yet recruiting
- Sponsor
- Tianjin Jizhou District People's Hospital
- Start
- Aug 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of nalbuphine, oxycodone, fentanyl and propofol in None (3 arms), sponsored by Tianjin Jizhou District People's Hospital. Primary endpoint: Total use of analgesics. Planned start Aug 2023; status: not yet recruiting.
02
Drugs
nalbuphineoxycodonefentanylpropofol
Beyond the preview
Go deeper on ChiCTR2300077446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300077446.